Voyager Therapeutics’ (VYGR) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on Thursday morning,Benzinga reports. The brokerage currently has a $30.00 price objective on the stock. A number of other equities analysts have also commented on VYGR. Wells Fargo & Company set a $10.00 target price on […]
HC Wainwright reissued their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on Thursday morning,Benzinga reports. The brokerage currently has a $30.00 price objective on the stock. A number of other equities analysts have also commented on VYGR. Wells Fargo & Company set a $10.00 target price on […]
